ProBio is a full-service, end-to-end CDMO for cell & gene therapy, with strong capabilities in plasmid and Adeno-associated virus (AAV) and Lentiviral Vector (LVV) development and manufacturing. Our fast, integrated, globally compliant platforms with proprietary technologies, reduce complexity and enable faster progression to clinic.